Neurotrack's competitors
Neurotrack's competitors include NeuraLace Medical, EXACT Sciences, bioMerieux and AbleTo
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Neurotrack Neurotrack's technology can predict the onset of Alzheimer's disease three to six years before symptoms occur. |  NeuraLace Medical NeuraLace Medical has developed a proprietary neuromodulation platform for direct and selective stimulation of sensory nerve fibers to manage neuropathic pain. |  EXACT Sciences Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer. |  bioMerieux bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. | |
Founding Date | Founding Date 2012 | Founding Date 2016 | Founding Date 1995 | Founding Date 1963 | Founding Date 2008 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Redwood City, US HQ | Locations San Diego, US HQ | Locations Madison, US HQ | Locations Marcy-l'Étoile, FR HQ | Locations New York, US HQ |
Employees | Employees 254% increase | Employees 8 | Employees 736 | Employees 9,8065% increase | Employees 2275% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 6.4 b | Valuation ($) 9.3 b | Valuation ($) N/A |
Facebook likes | Facebook likes 3.4 k | Facebook likes N/A | Facebook likes 5.4 k | Facebook likes 8.5 k | Facebook likes 785 |
Twitter followers | Twitter followers 1.3 k | Twitter followers 22 | Twitter followers 2 k | Twitter followers 4.8 k | Twitter followers 856 |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $99.4m (FY, 2016) | Revenue (est.) €2.1b (FY, 2016) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $45.2m (FY, 2016) | Cost of goods €1b (FY, 2016) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $54.2m (FY, 2016) | Gross profit €1.1b (FY, 2016) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income ($167.2m) (FY, 2016) | Net income €179.2m (FY, 2016) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 13.7m (2 months ago) | Latest funding round $ 2m (about 1 year ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 36.6m (9 months ago) |
Total funding raised | Total funding raised $ 26.1m | Total funding raised $ 2m | Total funding raised $ 8.2m | Total funding raised N/A | Total funding raised $ 36.6m |
For sources of this data, please see the company profileDownload Excel
View company profiles
NeuraLace Medical
HQ
San Diego, US
Employees
8
NeuraLace Medical has developed a proprietary neuromodulation platform for direct and selective stimulation of sensory nerve fibers to manage neuropathic pain.
View companyEXACT Sciences
HQ
Madison, US
Employees
736
Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.
View companybioMerieux
HQ
Marcy-l'Étoile, FR
Employees
9,806↑ 5% increase
bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety.
View company
AbleTo
HQ
New York, US
Employees
227↑ 5% increase
AbleTo is a technology-enabled provider of mental health care.
View company